Sonnet BioTherapeutics Holdings Inc. (SONN) is priced at $3.41 after the most recent trading session. At the very opening of the session, the stock price was $4.90 and reached a high price of $7.89, prior to closing the session it reached the value of $4.11. The stock touched a low price of $3.77.
Recently in News on July 20, 2020, Sonnet Biotherapeutics Announces Positive Preclinical Results from an Initial Efficacy Study Exploring the Combination of Granulocyte-Macrophage Colony-Stimulating Factor with Interleukins 18 and 12. PRINCETON, NJ / ACCESSWIRE / July 20, 2020 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing innovative targeted biologic drugs with enhanced mono or bispecific mechanisms, announced today that it has completed initial preclinical proof-of-concept work with both GMcSF and IL-18 and with GMcSF and IL-12 in a xenograft mouse model of melanoma. This study was designed to evaluate preclinical activity of the concomitantly administered cytokines as FHAB-derived molecules, using Sonnet’s Fully Human Albumin Binding (FHAB) technology, in several groups of tumor-bearing mice. Sonnet’s FHAB-derived drug candidates all showed statistically significant reduction in tumor growth compared to placebo and when compared to cytokines not derived from the Company’s platform. You can read further details here
Sonnet BioTherapeutics Holdings Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $54.60 on 03/19/20, with the lowest value was $2.52 for the same time period, recorded on 07/30/20.
Sonnet BioTherapeutics Holdings Inc. (SONN) full year performance was -78.07%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Sonnet BioTherapeutics Holdings Inc. shares are logging -93.75% during the 52-week period from high price, and 35.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.52 and $54.60.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1870989 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Sonnet BioTherapeutics Holdings Inc. (SONN) recorded performance in the market was -73.21%, having the revenues showcasing -17.14% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 26.80M, as it employees total of 587 workers.
Sonnet BioTherapeutics Holdings Inc. (SONN) in the eye of market guru’s
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.67, with a change in the price was noted -8.62. In a similar fashion, Sonnet BioTherapeutics Holdings Inc. posted a movement of -71.33% for the period of last 100 days, recording 2,132,960 in trading volumes.
Sonnet BioTherapeutics Holdings Inc. (SONN): Stocks Technical analysis and Trends
Raw Stochastic average of Sonnet BioTherapeutics Holdings Inc. in the period of last 50 days is set at 17.61%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 17.61%. In the last 20 days, the company’s Stochastic %K was 24.29% and its Stochastic %D was recorded 18.58%.
If we look into the earlier routines of Sonnet BioTherapeutics Holdings Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -73.21%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -75.31%, alongside a downfall of -78.07% for the period of the last 12 months. The shares increased approximately by 40.75% in the 7-day charts and went up by 12.30% in the period of the last 30 days. Common stock shares were lifted by -17.14% during last recorded quarter.